| abstract |
Provided herein are 3,5-diaminopyrazoles, such as compounds of formula IA, and pharmaceutical compositions thereof that are useful for modulating regulated in COPD kinase activity. Also provided herein are methods of use thereof for treating, preventing, or ameliorating one or more symptoms of an RC kinase mediated disorder, disease, or condition. [Chemical 1] [Selection figure] None |